Medicare Enrolled

Dr. Antonio Mancera, MD

Rheumatology · Laredo, TX
Practice pattern: Mixed Practice— Diverse clinical practice across multiple procedure types
Speaking/Promotional
7210 MCPHERSON RD, Laredo, TX 78041
9567288121
In practice since 2007 (18 years)
NPI: 1750565610 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Mancera from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Mancera? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Mancera

Dr. Antonio Mancera is a rheumatology in Laredo, TX, with 18 years in practice. Based on federal Medicare data, Dr. Mancera performed 143,131 Medicare services across 2,209 unique beneficiaries.

Between the years covered by Open Payments, Dr. Mancera received a total of $34,327 from 30 pharmaceutical and/or device companies across 429 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in rheumatology. The majority of payments are for speaking programs and promotional activities, reflecting participation in industry-sponsored events. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Mancera is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 18 years in practice▲ Top 10% volume in TX$ $34,327 industry payments

Medicare Practice Summary

Medicare Utilization ↗
143,131
Medicare services
Top 10% in TX for rheumatology
2,209
Unique beneficiaries
$11
Avg. Medicare payment
Medicare patients only (65+ / disabled) · Not a quality rating · How to read this →
~7,952 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

ProcedureVolumeAvg. paidAvg. submitted
Certolizumab injection (Cimzia)108,800$4$18
Abatacept infusion (Orencia)30,375$33$81
Administration of non-hormonal anti-neoplastic chemotherapy under skin or into muscle549$50$330
Administration of chemotherapy into vein, 1 hour or less471$92$330
Office visit, established patient (30-39 min)446$88$210
Steroid injection (triamcinolone)377$1$15
Blood creatinine level274$5$42
Liver function blood test panel271$8$44
Complete blood count (CBC) with differential270$8$42
C-reactive protein test (inflammation marker)261$5$45
Blood draw (venipuncture)169$8$35
Complete ultrasound scan of joint147$9$200
X-ray of hand, minimum of 3 views132$21$74
New patient office visit (45-59 min)109$110$265
Joint injection, major joint88$48$114
Chest X-ray, 2 views87$17$65
Knee X-ray, 3 views82$23$81
Foot X-ray, 3+ views66$20$72
Shoulder X-ray, 2+ views47$20$72
X-ray of lower and sacral spine, 2-3 views36$21$80
Hyaluronan or derivative, hyalgan, supartz or visco-3, for intra-articular injection, per dose27$57$190
X-ray of upper spine, 2-3 views17$18$105
X-ray of pelvis, 1-2 views17$14$76
Drug injection, under skin or into muscle13$10$65
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
21.2% high complexity
77.2% medium
1.6% routine

Industry Payment Transparency

Open Payments through 2024 ↗
$34,327
Total received (2018-2024)
Avg $4,904/year across 7 years
Top 13% in TX for rheumatology
30
Companies
429
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$28,673 (83.5%)
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$5,653 (16.5%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$2,066
2023
$928
2022
$337
2021
$14
2020
$181
2019
$12,903
2018
$17,897

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
Celgene Corporation
$15,029
AbbVie, Inc.
$11,265
Amgen Inc.
$3,213
UCB, Inc.
$817
Janssen Biotech, Inc.
$665
E.R. Squibb & Sons, L.L.C.
$642
Novartis Pharmaceuticals Corporation
$434
GlaxoSmithKline, LLC.
$335
ABBVIE INC.
$313
Aurinia Pharma U.S., Inc.
$272
AstraZeneca Pharmaceuticals LP
$242
Genentech USA, Inc.
$228
Lilly USA, LLC
$221
PFIZER INC.
$143
ANI Pharmaceuticals, Inc.
$101
Corcept Therapeutics
$69
Mallinckrodt Hospital Products Inc.
$45
Antares Pharma, Inc.
$42
AbbVie Inc.
$40
FIDIA PHARMA USA INC.
$34
ARBOR PHARMACEUTICALS, INC.
$31
Orthogenrx Inc.
$21
Ferring Pharmaceuticals Inc.
$18
GENZYME CORPORATION
$17
Ironwood Pharmaceuticals, Inc
$17
Zyla Life Sciences
$15
Organon LLC
$15
Alexion Pharmaceuticals, Inc.
$14
Horizon Therapeutics plc
$14
Mitsubishi Tanabe Pharma America, Inc.
$14
Top 3 companies account for 86.0% of total payments
Associated products mentioned in payments ›
ACTHAR · Actemra · BENLYSTA · Bimzelx · CHANTIX · COSENTYX · Cimzia · DUZALLO · EUFLEXXA · EVENITY · Enbrel · GenVisc 850 · HYALGAN · Horizant · Humira · Hymovis · INFLECTRA · KEVZARA · KRYSTEXXA · Korlym · LUPKYNIS · LYRICA · ORENCIA · Otezla · Otrexup · PURIFIED CORTROPHIN GEL · REMICADE · RENFLEXIS · RINVOQ · Radicava · Rinvoq · Rituxan · SAPHNELO · SIMPONI ARIA · SKYRIZI · SPRIX · STELARA · TALTZ · TAVNEOS · TREMFYA · Tavneos · XELJANZ
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

The majority of payments (84%) are for speaking programs and promotional activities, which reflect participation in industry-sponsored educational or marketing events. This is common in rheumatology and does not inherently indicate bias, but patients may wish to be aware.

Equivalent to $24 per 100 Medicare services performed
Looking for a rheumatology in Laredo?
Compare rheumatologys in the Laredo area by procedure volume, costs, and industry payment transparency.
Browse rheumatologys nearby

Geographic Context

Rheumatologys within 10 mi
1
Per 100K population
0.4
County median income
$62,506
Nearest hospital
DOCTORS HOSPITAL OF LAREDO
0.0 mi

Data Sources

Provider Registry NPPESWeekly updates
Medicare Enrollment PECOSMonthly updates
Practice Data Medicare Util.Annual (CY lag)
Industry Payments Open PaymentsCY 2024
Disciplinary History— Not publicN/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →

Summary

Dr. Mancera is a mixed practice specialist, with above-average Medicare volume (top 10% in TX), and high industry engagement (speaking/promotional, top 13%), with 18 years of practice experience.

This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →

Frequently Asked Questions

Is Dr. Mancera experienced with certolizumab injection (cimzia)?
Based on Medicare claims data, Dr. Mancera performed 108,800 certolizumab injection (cimzia) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Mancera receive payments from pharmaceutical companies?
Yes. Dr. Mancera received a total of $34,327 from 30 companies across 429 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Mancera's costs compare to other rheumatologys in Laredo?
Dr. Mancera's average Medicare payment per service is $11. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Mancera) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →